Benzinga
08 Jan 2026, 18:09 UTC · 40w ago
Neogen's Raised Outlook Fuels Turnaround Hopes, Stock Soars
Impact · against what's priced in
Neogen's stock is reacting to a meaningful upward revision in fiscal 2026 sales and EBITDA guidance, alongside an earnings beat. While the Animal Safety segment remains a drag and margins are compressed by tariffs, the overall shift in top and bottom-line expectations provides a positive catalyst for the turnaround narrative.
- NEOG+0.60
No priced-in read yet
- In context
Neogen raised fiscal 2026 sales guidance to $845 million–$855 million (from $820-$840 million) and beat consensus adjusted EPS by 4 cents, signaling a stronger recovery than previously anticipated despite an 11.8% decline in Animal Safety revenue.
Read from the article alone
Top 2 movers · tap to explore
